v3.26.1
SHARE-BASED COMPENSATION
3 Months Ended
Mar. 29, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation SHARE-BASED COMPENSATION
Stock Options

For the thirteen week periods ended March 29, 2026 and March 30, 2025, the Company recognized $0.1 million of compensation expense from continuing operations related to stock options. Unamortized share-based compensation expense from continuing operations as of March 29, 2026 amounted to $0.3 million which is expected to be recognized over the next 1.9 years. As of March 29, 2026, a total of 1.3 million shares remain available for issuance under 2013 Plan. A summary of stock option activity is presented as follows:
 Number of
Shares
Weighted Average Exercise Price Per ShareWeighted Average Remaining Contractual LifeTotal Intrinsic Value of Awards
(in thousands)
Options outstanding at December 28, 2025668,499 $13.52 5.2$52 
Options outstanding at March 29, 2026668,499 $13.52 5.0$124 
Options exercisable at December 28, 2025590,294 $14.36 4.7$52 
Options exercisable at March 29, 2026590,294 $14.36 4.5$123 
 Number of
Shares
Weighted Average Grant Date Fair Value
Non-vested outstanding at December 28, 202578,205 $3.45 
Non-vested outstanding at March 29, 202678,205 $3.45 

Restricted Stock

For the thirteen week periods ended March 29, 2026 and March 30, 2025, the Company recognized $0.1 million of compensation expense from continuing operations related to restricted stock awards. Unamortized share-based compensation expense as of March 29, 2026 amounted to $0.6 million which is expected to be recognized over the next 1.8 years. A summary of restricted stock activity is presented as follows:
 Number of
Shares
Weighted Average Exercise Price Per Share
Restricted outstanding at December 28, 2025
129,232 $5.96 
Issued16,770 $5.59 
Vested(12,244)$7.28 
Restricted outstanding at March 29, 2026
133,758 $5.79 
Non-vested outstanding at December 28, 2025
129,232 $5.96 
Non-vested outstanding at March 29, 2026
133,758 $5.79